BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2019 10:17:12 AM | Browse: 1509 | Download: 2158
 |
Received |
|
2019-03-11 09:18 |
|
Peer-Review Started |
|
2019-03-12 01:17 |
|
First Decision by Editorial Office Director |
|
2019-05-08 12:57 |
|
Return for Revision |
|
2019-05-09 02:00 |
|
Revised |
|
2019-05-13 07:26 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-05-13 11:15 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-05-14 01:32 |
|
Articles in Press |
|
2019-05-14 01:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-05-14 09:50 |
|
Publish the Manuscript Online |
|
2019-05-15 10:17 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Management of diabetic dyslipidemia: An update
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ishwarlal Jialal and Gurdeep Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ishwarlal Jialal, MD, PhD, Professor, California North-state University College of Medicine, VA Medical Center, Mather, 9700 West Taron Drive, Elk Grove, CA 95757, United States. ishwarlal.jialal@cnsu.edu |
| Key Words |
Diabetes; Dyslipidemia; Statins; Atherosclerosis; Ezetimibe |
| Core Tip |
Atherosclerotic cardiovascular disease (ASCVD) is the major cause of mortality in diabetes. Low-density lipoprotein (LDL)-cholesterol lowering with statins reduce ASCVD and is the mainstay of therapy. Also, both ezetimibe and PCSK9 inhibitors are useful strategies when statins cannot be tolerated or the LDL-cholesterol goal is not achieved. |
| Publish Date |
2019-05-15 10:17 |
| Citation |
Jialal I, Singh G. Management of diabetic dyslipidemia: An update. World J Diabetes 2019; 10(5): 280-290 |
| URL |
https://www.wjgnet.com/1948-9358/full/v10/i5/280.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v10.i5.280 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
